FR11C0037I2 - Antibiotiques macrolides et traitement de la pasteurellose - Google Patents

Antibiotiques macrolides et traitement de la pasteurellose

Info

Publication number
FR11C0037I2
FR11C0037I2 FR11C0037C FR11C0037C FR11C0037I2 FR 11C0037 I2 FR11C0037 I2 FR 11C0037I2 FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 I2 FR11C0037 I2 FR 11C0037I2
Authority
FR
France
Prior art keywords
pasteurellosis
treatment
derivatives
macrolid antibiotics
macrolid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0037C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zh Biseibutsu Kagaku Ke
Original Assignee
Zh Biseibutsu Kagaku Ke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zh Biseibutsu Kagaku Ke filed Critical Zh Biseibutsu Kagaku Ke
Publication of FR11C0037I1 publication Critical patent/FR11C0037I1/fr
Application granted granted Critical
Publication of FR11C0037I2 publication Critical patent/FR11C0037I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
FR11C0037C 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose Active FR11C0037I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24328699 1999-08-30
PCT/JP2000/005721 WO2001016148A1 (en) 1999-08-30 2000-08-24 Macrolide antibiotics and treatment of pasteurellosis

Publications (2)

Publication Number Publication Date
FR11C0037I1 FR11C0037I1 (enrdf_load_stackoverflow) 2011-10-14
FR11C0037I2 true FR11C0037I2 (fr) 2012-06-22

Family

ID=17101600

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0037C Active FR11C0037I2 (fr) 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose

Country Status (13)

Country Link
US (1) US6514946B1 (enrdf_load_stackoverflow)
EP (1) EP1216256B1 (enrdf_load_stackoverflow)
JP (1) JP4573411B2 (enrdf_load_stackoverflow)
AT (1) ATE261450T1 (enrdf_load_stackoverflow)
AU (1) AU763732B2 (enrdf_load_stackoverflow)
BE (1) BE2011C037I2 (enrdf_load_stackoverflow)
CA (1) CA2391834C (enrdf_load_stackoverflow)
DE (2) DE122011100013I1 (enrdf_load_stackoverflow)
DK (1) DK1216256T3 (enrdf_load_stackoverflow)
ES (1) ES2213597T3 (enrdf_load_stackoverflow)
FR (1) FR11C0037I2 (enrdf_load_stackoverflow)
PT (1) PT1216256E (enrdf_load_stackoverflow)
WO (1) WO2001016148A1 (enrdf_load_stackoverflow)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2595211C (en) 2005-01-24 2012-08-21 Microbial Chemistry Research Foundation Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative
US9148795B2 (en) * 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
ES2374950T3 (es) * 2006-07-28 2012-02-23 Intervet International B.V. Procedimiento de síntesis de macrolidos.
WO2008012343A2 (en) * 2006-07-28 2008-01-31 Intervet International B.V. Macrolide synthesis process
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
UA98303C2 (ru) * 2006-07-28 2012-05-10 Интервет Интернешонал Б.В. Способ синтеза макролидов
CN102863487B (zh) * 2012-10-08 2014-11-05 齐鲁动物保健品有限公司 20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的制备方法
HRP20180877T1 (hr) * 2013-05-23 2018-07-13 Bayer Animal Health Gmbh Derivati tilozina i postupci njihove priprave
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN108864228B (zh) * 2014-01-22 2021-02-02 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104558076A (zh) * 2015-02-10 2015-04-29 上海皓元化学科技有限公司 一种泰地罗新的制备方法及其中间体化合物
US10287275B2 (en) * 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN105440093A (zh) * 2015-11-17 2016-03-30 宁夏泰瑞制药股份有限公司 一种泰地罗新的合成方法
CN105919933A (zh) * 2016-06-13 2016-09-07 上海同仁药业股份有限公司 泰地罗新注射液及其制备方法
CN106420600A (zh) * 2016-09-21 2017-02-22 中国水产科学研究院珠江水产研究所 一种替米考星注射用原位凝胶及其制备方法
CN108264530A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 20,23-二卤代-5-o-碳霉胺糖基-泰乐内酯及其合成方法和应用
CN108264529A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 一种20,23-二哌啶-5-o-碳霉胺糖基-泰乐内酯的合成方法
ES3032032T3 (en) 2020-12-03 2025-07-15 Intervet Int Bv Tildipirosin for the treatment of foot rot
CN116731096B (zh) * 2023-06-10 2025-03-04 中国兽医药品监察所 20-醛基-23-哌啶基-5-o-碳霉胺糖基-泰乐内酯及其合成方法及它的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454314A (en) * 1982-08-02 1984-06-12 Pfizer Inc. Antibacterial mycaminosyl tylonolide and related macrolide derivatives
JPS5951299A (ja) * 1982-09-17 1984-03-24 Microbial Chem Res Found ２３−デオキシ−２０−ジヒドロ−マイカミノシルタイロノライド誘導体
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4629786A (en) 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド
JPS59227897A (ja) * 1983-06-10 1984-12-21 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド
US4604380A (en) * 1985-01-18 1986-08-05 Eli Lilly And Company C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
TW226373B (enrdf_load_stackoverflow) * 1992-07-15 1994-07-11 Pfizer

Also Published As

Publication number Publication date
AU763732B2 (en) 2003-07-31
ATE261450T1 (de) 2004-03-15
PT1216256E (pt) 2004-07-30
DE60008895T2 (de) 2005-01-20
WO2001016148A1 (en) 2001-03-08
BE2011C037I2 (enrdf_load_stackoverflow) 2019-10-16
CA2391834C (en) 2008-08-05
JP4573411B2 (ja) 2010-11-04
FR11C0037I1 (enrdf_load_stackoverflow) 2011-10-14
EP1216256B1 (en) 2004-03-10
JP2001139592A (ja) 2001-05-22
US6514946B1 (en) 2003-02-04
DK1216256T3 (da) 2004-06-21
DE122011100013I1 (de) 2011-09-15
DE60008895D1 (de) 2004-04-15
AU6729400A (en) 2001-03-26
CA2391834A1 (en) 2001-03-08
EP1216256A1 (en) 2002-06-26
ES2213597T3 (es) 2004-09-01

Similar Documents

Publication Publication Date Title
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
DE69330294D1 (de) Inter-hierarchisches Synchronisationssystem und LSI, das dieses System verwendet
ATE255104T1 (de) Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe
NO991012L (no) 3,6-Ketal- og enoleter-makrolid-antibiotika
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
IT8948696A0 (it) Composizione orale antibatterica, antiplacca, antitartaro
DE60331849D1 (de) Antibakterielle wirkstoffe
IS2350B (is) 13-atóma asalíð og notkun þeirra sem sýklalyfsmiðlar
MX9304301A (es) Derivados de macrolidas antibioticas con un anillo de 16 miembros.
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
HUP0004579A2 (hu) Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények
NO20025134L (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr
FI971643A7 (fi) Monityydyttymättömät hiilihydraattijohdannaiset, niiden polymeerit ja niiden käyttö
TR28331A (tr) 13-ikameli milbemisin türevleri, bunlarin hazirlanmalari ve kullanimlari.
BRPI9703099B8 (pt) derivado de carboidrato, e, composição farmacêutica
DE69010924D1 (de) Antibiotikum L53-18A und dessen Herstellung.
TR200103211T2 (tr) Streptococcus pneumoniae enfeksiyonlarının tedavisi.
MX9202034A (es) Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.
DE69004808D1 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
FR2784379B1 (fr) Derives de quinazolinedione, leurs preparations et leurs applications en therapeutique
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas
ES2181768T3 (es) Estalobacinas antibioticos.
NO20005157D0 (no) Regulerbar genekspresjon i gram-positive bakterier